Los Angeles Capital Management Equity Research Inc buys $72,377,950 stake in Clorox Co (CLX)

Clorox Co (CLX) : Los Angeles Capital Management Equity Research Inc scooped up 181,186 additional shares in Clorox Co during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 543,378 shares of Clorox Co which is valued at $72,377,950.Clorox Co makes up approximately 0.59% of Los Angeles Capital Management Equity Research Inc’s portfolio.

Other Hedge Funds, Including , Norinchukin Bank The boosted its stake in CLX in the latest quarter, The investment management firm added 141 additional shares and now holds a total of 6,784 shares of Clorox Co which is valued at $903,629. Clorox Co makes up approx 0.02% of Norinchukin Bank The’s portfolio.Investors Capital Advisory Services boosted its stake in CLX in the latest quarter, The investment management firm added 128 additional shares and now holds a total of 3,379 shares of Clorox Co which is valued at $444,643. Clorox Co makes up approx 0.09% of Investors Capital Advisory Services’s portfolio.First Manhattan Co boosted its stake in CLX in the latest quarter, The investment management firm added 315 additional shares and now holds a total of 17,307 shares of Clorox Co which is valued at $2,355,829. Clorox Co makes up approx 0.01% of First Manhattan Co’s portfolio.Palisade Asset Management reduced its stake in CLX by selling 200 shares or 3.8% in the most recent quarter. The Hedge Fund company now holds 5,060 shares of CLX which is valued at $693,524. Clorox Co makes up approx 0.13% of Palisade Asset Management’s portfolio.

Clorox Co closed down -1.18 points or -0.88% at $132.24 with 4,77,501 shares getting traded on Monday. Post opening the session at $133.16, the shares hit an intraday low of $132.2 and an intraday high of $133.41 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Clorox Co reported $1.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $1.28. The company had revenue of $1600.00 million for the quarter, compared to analysts expectations of $1587.79 million. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS.

Many Wall Street Analysts have commented on Clorox Co. Clorox Co was Initiated by Atlantic Equities to “Neutral” on Jun 14, 2016.

The Clorox Company (Clorox) is a United States-based manufacturer and marketer of consumer and professional products. The Company sells its products through mass retail outlets e-commerce channels distributors and medical supply providers. The Company operates through strategic business units that are aggregated into four reportable segments: Cleaning which consists of laundry home care and professional products marketed and sold in the United States; Household which consists of charcoal cat litter and plastic bags wraps and container products; Lifestyle which includes food products water-filtration systems and filters and natural personal care products and International which consists of products sold outside the United States such as laundry home care water-filtration charcoal and cat litter products dressings and sauces plastic bags wraps and containers and natural personal care products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Clorox Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Clorox Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.